Source: Discover Nano, by Hengameh Dortaj; Abbas Asoudeh-Fard; Aliakbar Alizadeh; Ahmad Vaez; Ahmad Gholami (September 21, 2026). AI-generated summary by biochip.com, published . Not independently reviewed.
Key takeaways
- The review proposes microfluidic lab-on-a-chip devices and SERS sensors for real-time detection of preclinical osteoarthritis nanobiomarkers.
- It links systems biology with biomimetic nanocomposites, electrospun scaffolds, and responsive nanocarriers to support cartilage regeneration.
- The roadmap does not establish clinical performance, patient testing, or regulatory readiness for the proposed diagnostic and therapeutic platforms.
Osteoarthritis is often treated as a problem of worn cartilage, but this review argues that the disease is a whole-joint disorder that needs equally comprehensive tools. Hengameh Dortaj and colleagues outline a roadmap that links systems biology, nanomedicine, diagnostics, tissue engineering, and material safety. The proposed diagnostic arm includes microfluidic lab-on-a-chip devices and surface-enhanced Raman scattering sensors, designed to detect molecular signals before visible joint damage becomes advanced. The therapeutic arm centers on nanoscale materials that more closely reproduce cartilage's natural structure and signaling environment. A third arm, called systems toxicology, would use computational analysis to assess how new nanomaterials interact with biology before they move toward clinical use. The review does not report a single new device tested in patients. Instead, it maps how molecular data and engineered materials could form a closed loop, where diagnosis guides treatment design and safety assessment informs material development. Its central message is that successful cartilage regeneration will require technologies that account for the biological complexity of osteoarthritis rather than treating the joint as a simple mechanical surface.
Why Osteoarthritis Resists Simple Fixes
Articular cartilage is the smooth, load-bearing tissue covering the ends of bones in synovial joints such as the knee. Its performance depends on an organized extracellular matrix, the supportive material outside cells, built largely from type II collagen fibers, aggrecan, and other molecules that retain water and resist compression.
Only a small population of chondrocytes, the cells that maintain cartilage, manages this dense matrix. The review argues that conventional treatments and early tissue-engineering efforts have fallen short partly because bulk materials cannot reproduce the native matrix's nanoscale architecture, meaning structural features measured in billionths of a meter.
Systems Biology as a Molecular Map
Systems biology approaches disease like a city map rather than a single street map. Instead of isolating one gene or one protein, it combines large biological datasets and computational models to identify interacting molecular disturbances across a disease process.
For osteoarthritis, the roadmap highlights transcriptomic and proteomic data. Transcriptomics measures patterns of RNA, which reflect which genes cells are using, while proteomics measures proteins, the molecules that carry out much of a cell's work. Network modeling can then connect these changes into candidate molecular blueprints for diagnosis and intervention.
Chips and Optical Sensors for Earlier Detection
The review identifies ultrasensitive diagnostic systems as a key bridge from molecular mapping to clinical decision-making. A lab-on-a-chip is a small device that channels tiny fluid volumes through miniaturized testing steps, much as a compact kitchen combines several cooking tasks in one space.
In this framework, microfluidic lab-on-a-chip devices could support real-time detection of preclinical nanobiomarkers, molecular signals associated with disease before conventional clinical signs are fully apparent. The review also points to surface-enhanced Raman scattering, or SERS, sensors, which amplify a light-based molecular fingerprint so small amounts of a target can be detected.
Building Materials That Resemble Cartilage
Diagnosis alone cannot restore a damaged joint, so the roadmap pairs sensing technologies with biomimetic nanomedicine. Biomimetic means designed to imitate biology, and here the target is cartilage's ordered extracellular matrix and the signals it gives resident cells.
The review discusses biomimetic nanocomposites, electrospun scaffolds with optimized surface topography, and stimuli-responsive nanocarriers. Electrospinning creates fine fibers that can be assembled into scaffold-like structures, while surface topography refers to the physical texture that cells encounter. Nanocarriers are engineered particles intended to deliver a payload in response to a specific biological or physical cue.
Restoring Chondrogenesis
The intended biological goal is chondrogenesis, the formation of cartilage. The proposed nanostructures are meant to provide both biophysical cues, such as structure and texture, and biochemical cues, such as molecular signals, that encourage cartilage-forming activity.
The review also frames this strategy as a way to counter catabolic inflammation. Catabolic processes break tissue down, so stopping inflammatory breakdown while supplying pro-regenerative signals could be more effective than relying on a scaffold or drug-delivery material alone.
Safety-by-Design Is Part of the Platform
Nanomaterials can behave differently from larger materials because their dimensions and surfaces shape how they interact with cells and tissues. The roadmap therefore places safety assessment alongside material design rather than treating it as a final hurdle after a promising product has been built.
Systems toxicology combines computational frameworks with biological information to examine potential harmful effects at a genomic scale. The authors present it as a translational bridge for pursuing genomic biocompatibility and safety-by-design, where anticipated biological risks inform choices about a nanomaterial's properties early in development.
Why This Matters
The review's most important platform idea is the closed loop between measurement, modeling, material design, and safety analysis. A sensitive chip or SERS sensor could identify molecular changes, systems biology could help interpret what those changes mean, and engineered nanomaterials could be selected to address the relevant biological disruptions.
That is a different proposition from simply making a stronger implant or measuring a single biomarker. It treats osteoarthritis as a condition involving interacting molecular, inflammatory, structural, and safety questions, each of which may influence whether a regenerative intervention ultimately helps patients.
From Roadmap to Clinical Testing
The next challenge is to turn this integrated vision into validated diagnostic and regenerative systems. That will require connecting molecular readouts to meaningful clinical decisions, engineering materials that reliably support cartilage formation, and applying safety-by-design throughout development. If those pieces can be joined, the approach could move osteoarthritis care toward more personalized strategies that detect disease earlier and match interventions to the biology of an individual joint.
Topics: Biosensors · Lab-on-a-chip · Diagnostics & precision medicine · Immunity & inflammation
Start here: Lab-on-a-chip explained